Fluconazole prophylaxis against fungal colonization and infection in preterm infants.
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Invasive fungal infection is associated with substantial morbidity and mortality in preterm infants. We evaluated the efficacy of prophylactic fluconazole in preventing fungal colonization and invasive infection in extremely-low-birth-weight infants. METHODS: We conducted a prospective, randomized, double-blind clinical trial over a 30-month period in 100 preterm infants with birth weights of less than 1000 g. The infants were randomly assigned during the first five days of life to receive either intravenous fluconazole or placebo for six weeks. We obtained weekly surveillance cultures from all patients. RESULTS: The 50 infants randomly assigned to fluconazole and the 50 control infants were similar in terms of birth weight, gestational age at birth, and base-line risk factors for fungal infection. During the six-week treatment period, fungal colonization was documented in 30 infants in the placebo group (60 percent) and 11 infants in the fluconazole group (22 percent; difference in risk, 0.38; 95 percent confidence interval, 0.18 to 0.56; P=0.002). Invasive fungal infection with positive growth of fungal isolates from the blood, urine, or cerebrospinal fluid developed in 10 infants in the placebo group (20 percent) and none of the infants in the fluconazole group (difference in risk, 0.20; 95 percent confidence interval, 0.04 to 0.36; P=0.008). The sensitivities of the fungal isolates to fluconazole did not change during the study, and no adverse effects of the fluconazole therapy were documented. CONCLUSIONS: Prophylactic administration of fluconazole during the first six weeks of life is effective in preventing fungal colonization and invasive fungal infection in infants with birth weights of less than 1000 g.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, antifungal prophylaxis is now routinely used for extremely premature newborns in some neonatal units and for patients with certain types of hematologic malignancies, dramatically reducing rates of candidemia in these populations (15,16).”
From Population-Based Active Surveillance for Culture-Confirmed Candidemia — Four Sites, United States, 2012–2016 (2019) · cites this paper as [16]
In the citing paper
“The high incidence of candidemia among infants, as well as the significant difference by race in this age group, was noted in the study of Kao et al. (16) and is known to be an important public health problem in this population (17, 35, 42).”
In the citing paper
“reduced the rate of invasive can-didiasis from 20% to 0% ( ) [344].”
From Guidelines for Treatment of Candidiasis (2004) · cites this paper as [344]
In the citing paper
“Regarding the latter observation, it is noteworthy that the formation of biofilms on central venous catheters by Candida spp. is associated with nosocomial infections (121, 122).”
From Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem (2007) · cites this paper as [121]
In the citing paper
“C. parapsilosis is notorious for the ability to form biofilms on catheters and other implanted devices (26, 38, 56, 80, 121, 122, 129, 269), for nosocomial spread by hand carriage, and for persistence in the hospital environment (38, 80, 122, 129, 262).”
From Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem (2007) · cites this paper as [121]
Citations
Cites
(2001) · Statistics for Psychologists · doi:10.4324/9781410605542-11 · Cited by 6,877
Hennekens, C. H., Buring, J. E., & Mayrent, S. L. (1987) · Medical Entomology and Zoology · Cited by 2,319
Manual of Clinical Microbiology, 7th ed.
Balows, A. (2000) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(99)00102-9 · Cited by 1,613
Assessing symptom distress in cancer patients: The M. D. Anderson Symptom Inventory
Cleeland, C. S., Mendoza, T. R., Wang, X. S., Chou, C., Harle, M. T., Morrissey, M., & Engstrom, M. C. (2000) · Cancer · doi:10.1002/1097-0142(20001001)89:7<1634::aid-cncr29>3.0.co;2-v · Cited by 1,360
Goodman, J. L., Winston, D. J., Greenfield, R. A., Chandrasekar, P. H., Fox, B., Kaizer, H., Shadduck, R. K., Shea, T. C., Stiff, P., Friedman, D. J., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203263261301 · Cited by 1,174
Reference method for broth dilution antifungal susceptibility testing of yeasts : Approved standard
Rex, J. H., & Clinical (2008) · Clinical and Laboratory Standards Institute eBooks · Cited by 1,052
Manual of clinical microbiology
Murray, P. R., Versalovic, J. A., & Jorgensen, J. H. (1999) · Cited by 880
Resistance of Candida species to fluconazole
Rex, J. H., Rinaldi, M. G., & Pfaller, M. A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.1.1 · Cited by 877
Stoll, B. J., Gordon, T., Korones, S. B., Shankaran, S., Tyson, J. E., Bauer, C. R., Fanaroff, A. A., Lemons, J. A., Donovan, E. F., Oh, W., et al. (1996) · The Journal of Pediatrics · doi:10.1016/s0022-3476(96)70191-9 · Cited by 873
Slavin, M. A., Osborne, B., Adams, R., Levenstein, M. J., Schoch, H. G., Feldman, A. R., Meyers, J. D., & Bowden, R. A. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/171.6.1545 · Cited by 820
Research works printed but not linked: 2
- Spicer AD, 1992, Med Microbiol Lett, 1, 284
- 10.1111/j.1574-6968.2000.tb08938.x · doi:10.1111/j.1574-6968.2000.tb08938.x · Paper page
Cited by
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200
“cantly reduced rates of invasive candidiasis in premature neonates weighing <1000 g in nurseries with a very high incidence of Candida infections [300, 302].”
BackgroundEpidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174
“parapsilosis in the neonatal setting (117), a recent example of the emergence of fluconazole resistance in a strain endemic to a Finnish neonatal ICU underscores the importance of good infection control practices, rather than antifungal prophylaxis, in preventing infection with C.”
BackgroundPappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191
“In 2 recent studies, the incidence of candidiasis in the placebo arms were 20% in neonates weighing !1000 g and 13% in neonates weighing 1000–1500 g [240, 241].”
BackgroundGuidelines for Treatment of Candidiasis
Pappas, P. G., Rex, J. H., Sobel, J. D., Filler, S. G., Dismukes, W. E., Walsh, T. J., & Edwards, J. E. (2004) · Clinical Infectious Diseases · doi:10.1086/380796 · Cited by 1,440
“the third and fourth weeks of life, and every day during the fifth and sixth weeks of life) reduced the rate of invasive candidiasis from 20% to 0% ( ) [344].”
BackgroundCandida parapsilosis, an Emerging Fungal Pathogen
Trofa, D., Gácser, A., & Nosanchuk, J. D. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00013-08 · Cited by 854
“parapsilosis, although their durations were only 14 to 30 months (133, 135).”
BackgroundZaoutis, T. E., Argon, J., Chu, J., Berlin, J. A., Walsh, T. J., & Feudtner, C. (2005) · Clinical Infectious Diseases · doi:10.1086/496922 · Cited by 784
Candida Infections of the Genitourinary Tract
Achkar, J. M., & Fries, B. C. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00076-09 · Cited by 736
“A second patient population at risk are prematurely born neonates, especially those who received antibiotic treatment and have indwelling lines (111, 135, 159, 164, 165).”
BackgroundResultBenjamin, D. K., Stoll, B. J., Fanaroff, A. A., McDonald, S. A., Oh, W., Higgins, R. D., Duara, S., Poole, K., Laptook, A., Goldberg, R., et al. (2006) · Pediatrics · doi:10.1542/peds.2004-2292 · Cited by 667
Hajjeh, R. A., Sofair, A. N., Harrison, L. H., Lyon, G. M., Arthington-Skaggs, B. A., Mirza, S. A., Phelan, M., Morgan, J., Lee-Yang, W., Ciblak, M. A., et al. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.4.1519-1527.2004 · Cited by 649
“Age (yr) 1 43 (8) 29 (5) 8 (3) 2 (1) 18 (12) 72 (7) 1–19 24 (5) 25 (4) 1 ( 1) 7 (5) 5 (3) 49 (4) 20–44 88 (17) 113 (18) 42 (15) 28 (20) 26 (17) 201 (18) 45–64 129 (25) 178 (28) 82 (30) 42 (30) 41 (27) 307 (27) 65 232 (45) 281 (45) 142 (52) 62 (44) 63 (41) 514 (45)”
BackgroundInfluentialChanging patterns and trends in systemic fungal infections
Richardson, M. D. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki218 · Cited by 525
“[8, 16, 29, 30, 31] The incidence increases in an inverse linear pattern, from around 3% at 28 weeks' gestation to 24% at 23 weeks' gestation.”
BackgroundCamacho-Gonzalez, A., Spearman, P. W., & Stoll, B. J. (2013) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2012.12.003 · Cited by 459
Clinical Microbiology of Bacterial and Fungal Sepsis in Very-Low-Birth-Weight Infants
Kaufman, D., & Fairchild, K. D. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.3.638-680.2004 · Cited by 435
“In one study of ELBW infants, the incidence of fungal UTI was 6% (3 of 50), and 1 of 8 infants with fungal sepsis had Candida UTI (246).”
BackgroundInfluentialSelf-citationNeonatal Candidiasis: Epidemiology, Risk Factors, and Clinical Judgment
Benjamin, D. K., Stoll, B. J., Gantz, M. G., Walsh, M. C., Sánchez, P. J., Das, A., Shankaran, S., Higgins, R. D., Auten, K. J., Miller, N. A., et al. (2010) · Pediatrics · doi:10.1542/peds.2009-3412 · Cited by 375
Hope, W. W., Castagnola, E., Groll, A. H., Roilides, E., Akova, M., Arendrup, M. C., Arikan-Akdagli, S., Bassetti, M., Bille, J., Cornely, O. A., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12040 · Cited by 360
“Concerns for neurodevelopmental toxicity, emergence of resistant species [19,25–37,39]”
BackgroundA Multicenter, Randomized Trial of Prophylactic Fluconazole in Preterm Neonates
Manzoni, P., Stolfi, I., Pugni, L., Decembrino, L., Magnani, C., Vetrano, G., Tridapalli, E., Corona, G., Giovannozzi, C., Farina, D., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065733 · Cited by 356
Pediatric Urinary Tract Infections
Chang, S. L., & Shortliffe, L. D. (2006) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2006.02.011 · Cited by 354
Manzoni, P., Mostert, M., Leonessa, M. L., Priolo, C., Farina, D., Monetti, C., Latino, M. A., & Gomirato, G. (2006) · Clinical Infectious Diseases · doi:10.1086/504324 · Cited by 305
“[16] achieved a 3-fold reduction in stool or rectal fungal colonization in neonates with a birth weight of !1250 or !1000 g, respectively.”
BackgroundNeonatal sepsis: Progress towards improved outcomes
Shane, A. L., & Stoll, B. J. (2014) · Journal of Infection · doi:10.1016/j.jinf.2013.09.011 · Cited by 297
“Prophylactic administration of fluconazole during the first six weeks of life reduces fungal colonization and invasive fungal infection in extremely low birthweight infantsdthose with birthweights <1000 g.(36) In addition to the individual benefit afforded by prophylaxis for VLBW neonates, fluconazole prophylaxis may…”
BackgroundFridkin, S. K., Kaufman, D., Edwards, J. R., Shetty, S., Horan, T., & Hospitals, T. N. N. I. S. S. (2006) · Pediatrics · doi:10.1542/peds.2005-1996 · Cited by 284
Self-citationManagement of candidiasis Management of Candida species infections in critically ill patients
Eggimann, P., Garbino, J., & Pittet, D. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00831-4 · Cited by 234
Benjamin, D. K., Poole, C., Steinbach, W. J., Rowen, J. L., & Walsh, T. J. (2003) · Pediatrics · doi:10.1542/peds.112.3.634 · Cited by 236
van Asbeck, E. C., Clemons, K. V., & Stevens, D. A. (2009) · Critical Reviews in Microbiology · doi:10.3109/10408410903213393 · Cited by 210
“Very low birth weight children, during the first six weeks of life, have an increased risk for candidemia caused by C. parapsilosis (Kaufman et al. 2001).”
BackgroundZaoutis, T. E., Prasad, P. A., Localio, A. R., Coffin, S. E., Bell, L. M., Walsh, T. J., & Gross, R. (2010) · Clinical Infectious Diseases · doi:10.1086/655698 · Cited by 208
“Antifungal prophylaxis has been an effective preventative strategy in other pediatric populations at high risk for candidemia, including neonates and oncology patients [8, 9].”
BackgroundCandida parapsilosis Is a Significant Neonatal Pathogen: A Systematic Review and Meta-analysis
Pammi, M., Holland, L., Butler, G., Gacser, A., & Bliss, J. M. (2013) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3182863a1c · Cited by 206
“These results have led to wide adoption of targeted fluconazole prophylaxis strategy in neonatal intensive care units for VLBW infants to prevent invasive candidiasis.(86,87) Controversy remains as to whether widespread use of fluconazole in neonatal units has increased azole resistance among Candida isolates or alter…”
ResultInvasive Trichosporon Infection: a Systematic Review on a Re-emerging Fungal Pathogen
de Almeida Júnior, J. N., & Hennequin, C. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01629 · Cited by 206
“…India *Correspondence: João Nobrega de Almeida Júnior jnaj99@gmail.com Specialty section: This article was submitted to Infectious Diseases, a section of the journal Frontiers in Microbiology Received: 25 June 2016 Accepted: 29 September 2016 Published: 17 October 2016 Citation: de Almeida…”
BackgroundInfluentialBlyth, C. C., Chen, S. C. A., Slavin, M. A., Serena, C., Nguyen, Q., Marriott, D., Ellis, D., Meyer, W., Sorrell, T. C., & Study, O. B. O. M. O. T. A. C. (2009) · Pediatrics · doi:10.1542/peds.2008-2055 · Cited by 206
Toda, M., Williams, S. R., Berkow, E. L., Farley, M. M., Harrison, L. H., Bonner, L., Marceaux, K. M., Hollick, R., Zhang, A. Y., Schaffner, W., et al. (2019) · MMWR Surveillance Summaries · doi:10.15585/mmwr.ss6808a1 · Cited by 198
“Hepatitis C 66 (4) 165 (16) 54 (16) 67 (13) 352 (10)”
BackgroundInfluentialEmpirical Therapy for Neonatal Candidemia in Very Low Birth Weight Infants
Benjamin, D. K., DeLong, E. R., Steinbach, W. J., Cotton, C. M., Walsh, T. J., & Clark, R. H. (2003) · Pediatrics · doi:10.1542/peds.112.3.543 · Cited by 199
Cleminson, J., Austin, N., & McGuire, W. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003850.pub5 · Cited by 194
Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?
Charlier, C., Hart, E., Lefort, A., Ribaud, P., Dromer, F., Denning, D. W., & Lortholary, O. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki473 · Cited by 184
The Pharmacokinetics and Safety of Micafungin, a Novel Echinocandin, in Premature Infants
Heresi, G. P., Gerstmann, D. R., Reed, M. D., van den Anker, J. N., Blumer, J. L., Kovanda, L., Keirns, J. J., Buell, D. N., & Kearns, G. L. (2006) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000245103.07614.e1 · Cited by 183
Sarvikivi, E., Lyytikäinen, O., Soll, D. R., Pujol, C., Pfaller, M. A., Richardson, M., Koukila-Kähkölä, P., Luukkainen, P., & Saxén, H. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.6.2729-2735.2005 · Cited by 178
“In VLBW infants, prevention of fungal colonization by fluconazole prophylaxis has been shown to be effective (10, 11).”
BackgroundInfluentialManzoni, P., Farina, D., Leonessa, M., d'Oulx, E. A., Galletto, P., Mostert, M., Miniero, R., & Gomirato, G. (2006) · Pediatrics · doi:10.1542/peds.2006-1311 · Cited by 177
Manzoni, P., Stolfi, I., Messner, H., Cattani, S., Laforgia, N., Romeo, M. G., Bollani, L., Rinaldi, M., Gallo, E., Quercia, M., et al. (2012) · Pediatrics · doi:10.1542/peds.2011-0279 · Cited by 170
Strunk, T., Molloy, E. J., Mishra, A., & Bhutta, Z. A. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00495-1 · Cited by 193
Kaufman, D., Boyle, R., Hazen, K. C., Patrie, J. T., Robinson, M., & Grossman, L. B. (2005) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2005.03.036 · Cited by 164
Self-citationEpidemiologia das infecções hematogênicas por Candida spp
Colombo, A. L., & Guimarães, T. (2003) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/s0037-86822003000500010 · Cited by 292
Risk factors for candidemia in critically ill infants: a matched case-control study.
Feja, K. N., Wu, F., Roberts, K., Loughrey, M., Nesin, M., Larson, E., Della-Latta, P., Haas, J., Cimiotti, J., & Saiman, L. (2005) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2005.02.021 · Cited by 153
Manzoni, P., Arisio, R., Mostert, M., Leonessa, M., Farina, D., Latino, M. A., & Gomirato, G. (2006) · Pediatrics · doi:10.1542/peds.2004-2227 · Cited by 154
Changes in the Incidence of Candidiasis in Neonatal Intensive Care Units
Aliaga, S., Clark, R. H., Laughon, M., Walsh, T. J., Hope, W. W., Benjamin, D. K., Kaufman, D., Arrieta, A., Benjamin, D. K., & Smith, P. B. (2014) · Pediatrics · doi:10.1542/peds.2013-0671 · Cited by 154
Self-citationPatel, S., & Saiman, L. M. (2010) · Clinics in Perinatology · doi:10.1016/j.clp.2010.06.004 · Cited by 172
Healy, C. M., Campbell, J. R., Zaccaria, E., & Baker, C. J. (2008) · Pediatrics · doi:10.1542/peds.2007-1130 · Cited by 153
“99 Necrotizing enterocolitis, n (%) 1 (5) 6 (27) .”
Stoll, B., & Shane, A. (2013) · American Journal of Perinatology · doi:10.1055/s-0032-1333413 · Cited by 150
Roilides, E., Farmaki, E., Evdoridou, J., Dotis, J., Hatziioannidis, E., Tsivitanidou, M., Bibashi, E., Filioti, I., Sofianou, D., Gil‐Lamaignere, C., et al. (2004) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-004-1210-9 · Cited by 157
“While fluconazole prophylaxis may be effective in infants with birth weights of <1,000 g in centers with high rates [37] of infection, it is uncertain whether a lack of resistance will persist if prophylaxis becomes generalized.”
BackgroundCentral venous lines in neonates: a study of 2186 catheters
Cartwright, D. (2004) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/adc.2004.049189 · Cited by 140
Benjamin, D. K., Hudak, M. L., Duara, S., Randolph, D. A., Bidegain, M., Mundakel, G. T., Natarajan, G., Burchfield, D. J., White, R. D., Shattuck, K. E., et al. (2014) · JAMA · doi:10.1001/jama.2014.2624 · Cited by 136
“Postnatal age at treatment onset, median (25th-75th percentile), d 4 (3-5) 4 (3-4)”
BackgroundInfluentialSelf-citationA review of Candida species causing blood stream infection
Giri, S., & Kindo, A. (2012) · Indian Journal of Medical Microbiology · doi:10.4103/0255-0857.99484 · Cited by 127
Infectious Causes of Necrotizing Enterocolitis
Coggins, S. A., Wynn, J. L., & Weitkamp, J.-H. (2014) · Clinics in Perinatology · doi:10.1016/j.clp.2014.10.012 · Cited by 139
Safety and Pharmacokinetics of Repeat-Dose Micafungin in Young Infants
Benjamin, D. K., Smith, P. B., Arrieta, A., Castro, L., Sánchez, P. J., Kaufman, D., Arnold, L. J., Kovanda, L. L., Sawamoto, T., Buell, D. N., et al. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.200 · Cited by 131
Self-citationPfaller, M. A., Messer, S. A., Hollis, R. J., Boyken, L., Tendolkar, S., Kroeger, J., & Diekema, D. J. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.00946-09 · Cited by 129
“gence of fluconazole resistance, most were not conducted over a period long enough to demonstrate such a change (39).”
BackgroundThe Epidemiology and Diagnosis of Invasive Candidiasis Among Premature Infants
Kelly, M. S., Benjamin, D. K., & Smith, P. B. (2014) · Clinics in Perinatology · doi:10.1016/j.clp.2014.10.008 · Cited by 139
“1), although up to 5% to 10% of very low-birth-weight (VLBW; birth weight <1500 g) infants colonized by Candida develop invasive disease.(18,20,24,25) Premature infants are predisposed to invasive candidiasis for several”
Prevention and treatment of neonatal nosocomial infections
Ramasethu, J. (2017) · Maternal Health Neonatology and Perinatology · doi:10.1186/s40748-017-0043-3 · Cited by 161
The global epidemiology of invasive Candida infections—is the tide turning?
Hobson, R. P. (2003) · Journal of Hospital Infection · doi:10.1016/j.jhin.2003.08.012 · Cited by 137
Healy, C. M., Baker, C. J., Zaccaria, E., & Campbell, J. R. (2005) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2005.04.016 · Cited by 127
Neurodevelopmental Outcome of Extremely Low Birth Weight Infants with Candida Infection
Adams-Chapman, I. S., Bann, C., Das, A., Goldberg, R. N., Stoll, B. J., Walsh, M. C., Sánchez, P. J., Higgins, R. D., Shankaran, S., Watterberg, K. L., et al. (2013) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2013.04.034 · Cited by 117
Strategies for the prevention of hospital-acquired infections in the neonatal intensive care unit
Borghesi, A., & Stronati, M. (2008) · Journal of Hospital Infection · doi:10.1016/j.jhin.2008.01.011 · Cited by 113
“in a prospective randomised clinical trial.(50) Fluconazole was administered prophylactically for the first six weeks of life to ELBW neonates at high risk of Candida infection (when a CVC or an endotracheal tube were in place).”
MethodFluconazole Dosing for the Prevention or Treatment of Invasive Candidiasis in Young Infants
Wade, K. C., Benjamin, D. K., Kaufman, D. A., Ward, R. M., Smith, P. B., Jayaraman, B., Adamson, P. C., Gastonguay, M. R., & Barrett, J. S. (2009) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31819f1f50 · Cited by 117
“25 to 4 g/mL.(10,11,18,19) Dosing regimens that maintain T MIC of at least 40% may prevent the emergence of more resistant Candida isolates in vitro(12).”
BackgroundMethodSelf-citationBertini, G., Perugi, S., Dani, C., Filippi, L., Pratesi, S., & Rubaltelli, F. F. (2005) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2005.02.020 · Cited by 116
Uko, S., Soghier, L. M., Vega, M., Marsh, J., Reinersman, G. T., Herring, L., Dave, V. A., Nafday, S., & Brion, L. P. (2006) · Pediatrics · doi:10.1542/peds.2005-1969 · Cited by 111
Risk factors and prevention of late-onset sepsis in premature infants
Downey, L. C., Smith, P. B., & Benjamin, D. K. (2010) · Early Human Development · doi:10.1016/j.earlhumdev.2010.01.012 · Cited by 134
“A randomized placebo controlled study of 100 ELBW infants given fluconazole prophylaxis or placebo in the first 6 weeks of life demonstrated a significant reduction in invasive fungal disease [42].”
MethodPopulation Pharmacokinetics of Amphotericin B Lipid Complex in Neonates
Würthwein, G., Groll, A. H., Hempel, G., Adler‐Shohet, F. C., Lieberman, J. M., & Walsh, T. J. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.12.5092-5098.2005 · Cited by 109
“The reported frequency in very-low-birth-weight infants, the neonatal population at highest risk, is as high as 20%, with a case fatality rate as high as 50% despite the best available treatment (33, 41, 43).”
BackgroundSafety of dermatologic medications in pregnancy and lactation
Butler, D. C., Heller, M. M., & Murase, J. E. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.09.009 · Cited by 125
Nosocomial or Hospital-acquired Infections: An Overview
McFee, R. B. (2009) · Disease-a-Month · doi:10.1016/j.disamonth.2009.03.014 · Cited by 102
“12, [73] [74] [75] Not unlike other patients, newborns, even those not requiring NICU care, are susceptible to HAI.”
BackgroundHospital-Acquired Infections in the NICU: Epidemiology for the New Millennium
Carey, A. J., Saiman, L. M., & Polin, R. A. (2008) · Clinics in Perinatology · doi:10.1016/j.clp.2007.11.014 · Cited by 114
Manzoni, P., Leonessa, M., Galletto, P., Latino, M. A., Arisio, R., Maule, M., Agriesti, G., Gastaldo, L., Gallo, E., Mostert, M., et al. (2008) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e318170bb0c · Cited by 93
Magill, S. S., Swoboda, S. M., Johnson, E. A., Merz, W. G., Pelz, R. K., Lipsett, P. A., & Hendrix, C. W. (2006) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2006.03.013 · Cited by 107
“this and other factors, antifungal prophylaxis has emerged as an appealing strategy in high-risk patients and has been shown to reduce the incidence of IC in select clinical settings (Goodman et al., 1992; Slavin et al., 1995; Winston et al., 1999; Kaufman et al., 2001), including the ICU (Eggimann et al.”
BackgroundKumar, S., Bansal, A., Chakrabarti, A., & Singhi, S. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31826a409c · Cited by 98
“Using prophylactic intravenous fluconazole, a three-fold reduction in rectal colonization was achieved in preterm neonates (19).”
Candidemia in Neonatal Intensive Care Units: Barcelona, Spain
Rodriguez, D., Almirante, B., Park, B. J., Cuenca-Estrella, M., Planes, A. M., Sanchez, F., Gene, A., Xercavins, M., Fontanals, D., Rodriguez-Tudela, J. L., et al. (2006) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000202127.43695.06 · Cited by 99
Outcomes Attributable to Neonatal Candidiasis
Zaoutis, T. E., Heydon, K., Localio, R., Walsh, T. J., & Feudtner, C. (2007) · Clinical Infectious Diseases · doi:10.1086/513196 · Cited by 96
“One single-center, randomized clinical trial has supported the use of antifungal prophylaxis for the prevention of candidiasis in ELBW infants; however, the incidence of candidiasis at that center was extremely high [4].”
BackgroundInvasive fungal infection in very low birthweight infants: national prospective surveillance study
Clerihew, L., Lamagni, T. L., Brocklehurst, P., & McGuire, W. L. (2005) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/adc.2005.082024 · Cited by 101
Chaudhuri, J., Sarkar, D., Ghosh, P., Chakraborty, S., & Roy, A. (2014) · North American Journal of Medical Sciences · doi:10.4103/1947-2714.125870 · Cited by 95
“Systemic antifungal drugs have shown promising results, but antifungal prophylaxis raises concerns about selection of resistant strains.[17-19]”
BackgroundResultManagement of neonatal candidiasis
ROWEN, J. L., & TATE, J. M. (1998) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199811000-00008 · Cited by 93
Weighing the Hazards of Erythropoiesis Stimulation in Patients with Cancer
Khuri, F. R. (2007) · New England Journal of Medicine · doi:10.1056/nejmp078101 · Cited by 105
Colonization and epithelial adhesion in the pathogenesis of neonatal candidiasis
Bendel, C. M. (2003) · Seminars in Perinatology · doi:10.1016/s0146-0005(03)00059-4 · Cited by 105
Hazen, K. C., Baron, E. J., Colombo, A. L., Girmenia, C., Sanchez-Sousa, A., del Palacio, A., de Bedout, C., & Gibbs, D. L. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.12.5623-5632.2003 · Cited by 98
“A recent study has shown that prophylactic fluconazole therapy of very low birth weight (preterm) newborns during their first 6 weeks of life lowers the likelihood of developing serious yeast infections (8).”
BackgroundSelf-citationFluconazole prophylaxis in extremely low birth weight infants: association with cholestasis
Aghai, Z. H., Mudduluru, M., Nakhla, T., Amendolia, B., Longo, D., Kemble, N., Kaki, S., Sutsko, R. P., Saslow, J. G., & Stahl, G. E. (2006) · Journal of Perinatology · doi:10.1038/sj.jp.7211570 · Cited by 100
“In 2001, Kaufman et al.(4) reported results of a small randomized clinical trial showing that the prophylactic intravenous administration of fluconazole prevented fungal colonization and invasive fungal disease in extremely low birth weight (ELBW) infants without adverse effects. In 2005 and 2006, three studies report…”
Risk of resistance associated with fluconazole prophylaxis: Systematic review
Brion, L. P., Uko, S. E., & Goldman, D. L. (2007) · Journal of Infection · doi:10.1016/j.jinf.2006.11.017 · Cited by 102
Vardakas, K. Z., Samonis, G., Michalopoulos, A., Soteriades, E. S., & Falagas, M. E. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000208357.05675.c3 · Cited by 91
Interventions To Prevent Retinopathy of Prematurity: A Meta-analysis
Fang, J. L., Sorita, A., Carey, W. A., Colby, C. E., Murad, M. H., & Alahdab, F. (2016) · PEDIATRICS · doi:10.1542/peds.2015-3387 · Cited by 88
Neonatal candidiasis: Diagnosis, prevention, and treatment
Greenberg, R. G., & Benjamin, D. K. (2014) · Journal of Infection · doi:10.1016/j.jinf.2014.07.012 · Cited by 89
Antifungals in Systemic Neonatal Candidiasis
Frattarelli, D. A. C., Reed, M. D., Giacoia, G. P., & Aranda, J. V. (2004) · Drugs · doi:10.2165/00003495-200464090-00003 · Cited by 86
Benedict, K., Roy, M., Kabbani, S., Anderson, E. J., Farley, M. M., Harb, S., Harrison, L. H., Bonner, L., Wadu, V. L., Marceaux, K., et al. (2018) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piy009 · Cited by 81
Patterns of Fungal Colonization in Preterm Infants Weighing Less Than 1000 Grams at Birth
Kaufman, D. A., Gurka, M. J., Hazen, K. C., Boyle, R., Robinson, M. L., & Grossman, L. B. (2006) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000226978.96218.e6 · Cited by 89
“This is the same period when approximately one-half of late onset infections occur, therefore waiting until colonization is identified is often too late to institute preventative strategies.(2,9,15,23) Strategies aimed at prevention must occur before identifying initial colonization.”
BackgroundMethodResultSelf-citationCandida infections in the neonate
Chapman, R. L. (2003) · Current Opinion in Pediatrics · doi:10.1097/00008480-200302000-00016 · Cited by 82
Trends in Candida Central Line-Associated Bloodstream Infections Among NICUs, 1999–2009
Chitnis, A. S., Magill, S. S., Edwards, J. R., Chiller, T. M., Fridkin, S. K., & Lessa, F. C. (2012) · Pediatrics · doi:10.1542/peds.2011-3620 · Cited by 78
Shetty, S. S., Harrison, L. H., Hajjeh, R. A., Taylor, T., Mirza, S. A., Schmidt, A. B., Sanza, L. T., Shutt, K. A., & Fridkin, S. K. (2005) · Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000168751.11375.d6 · Cited by 78
“Prophylaxis with fluconazole has been shown to be beneficial in preventing invasive candidiasis in a number of high risk populations, and a recent study indicates that neonates may benefit as well.(16) In conclusion, our findings may further define a subgroup of infants that might benefit from prophylaxis with flucona…”
ResultOral nystatin prophylaxis to prevent invasive candidiasis in Neonatal Intensive Care Unit
Öztürk, M. A., Güneş, T., Köklü, E., Çetin, N., & Koç, N. (2006) · Mycoses · doi:10.1111/j.1439-0507.2006.01274.x · Cited by 83
Antifungal chemotherapy: advances and perspectives
Groll, A., & Walsh, T. (2002) · Swiss Medical Weekly · doi:10.4414/smw.2002.09729 · Cited by 76
Invasive fungal infections in neonates: a review
Weimer, K. E. D., Smith, P. B., Puia‐Dumitrescu, M., & Aleem, S. (2021) · Pediatric Research · doi:10.1038/s41390-021-01842-7 · Cited by 91
Oral nystatin prophylaxis and neonatal fungal infections
Howell, A. J., Isaacs, D., Halliday, R. J., & Infections, T. A. S. G. F. N. (2009) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/adc.2008.157123 · Cited by 75
“the combined incidence of invasive fungal infection in the four randomised controlled trials was 14.2% (30 of 211). The incidence for extremely low birth weight (ELBW) babies (”
BackgroundInfluential(2007) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-007-0337-0 · Cited by 96
“Die in vielen nicht ausschließlich US-amerikanischen Zentren praktizierte Fluconazol-Primärprophylaxe [356, 459, 460, 461, 462, 463, 464] spiegelt die ungleich höhere Inzidenz von Candidainfektionen in den Vereinigten Staaten wider [465] und ist nicht Gegenstand dieser Empfehlung.”
BackgroundAydemir, C., Oguz, S. S., Dizdar, E. A., Akar, M., Sarikabadayi, Y. U., Saygan, S., Erdeve, O., & Dilmen, U. (2011) · Archives of Disease in Childhood - Fetal and Neonatal Edition · doi:10.1136/adc.2009.178996 · Cited by 74
“4 Kicklighter et al showed that the prophylactic administration of fl uconazole to VLBW infants for the fi rst 28 days of life is safe and results in a decreased risk for Candida colonisation.”
BackgroundManzoni, P., Farina, D., Galletto, P., Leonessa, M., Priolo, C., Arisio, R., & Gomirato, G. (2007) · Journal of Perinatal Medicine · doi:10.1515/jpm.2007.055 · Cited by 75
Fungal infection in the very low birthweight infant
Kaufman, D. A. (2004) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200406000-00014 · Cited by 77
Self-citationLäer, S., Barrett, J. S., & Meibohm, B. (2009) · The Journal of Clinical Pharmacology · doi:10.1177/0091270009337513 · Cited by 70
“49,50 At least 90% of the most preterm infants achieved the minimum AUC of 400 mg ⋅ h/L. Figure 3 illustrates the ability of the model to generalize across developmental stage and organ status (renal insufficiency) with respect to exposure metrics used to judge the efficacy of fluconazole in…”
BackgroundLong, S. S., & Stevenson, D. K. (2005) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2005.04.033 · Cited by 70
Antifungal Prophylaxis to Prevent Neonatal Candidiasis: A Survey of Perinatal Physician Practices
Burwell, L. A., Kaufman, D., Blakely, J., Stoll, B. J., & Fridkin, S. K. (2006) · Pediatrics · doi:10.1542/peds.2006-0446 · Cited by 69
Self-citationEricson, J. E., Kaufman, D. A., Kicklighter, S. D., Bhatia, J., Testoni, D., Gao, J., Smith, P. B., Prather, K. O., & Benjamin, D. K. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw363 · Cited by 68
“Trial 2 [11] 1998–2000 <1000 g 5 d 3 mg/kg every 72 h for 2 wk, every 48 h for 2 wk, then daily 6 wk Liver failure”
BackgroundMethodSelf-citationWeitkamp, J.-H., Ozdas, A., LaFleur, B., & Potts, A. L. (2008) · Journal of Perinatology · doi:10.1038/sj.jp.7211914 · Cited by 69
Postbiotics against Pathogens Commonly Involved in Pediatric Infectious Diseases
Mantziari, A., Salminen, S., Szajewska, H., & Malagón-Rojas, J. N. (2020) · Microorganisms · doi:10.3390/microorganisms8101510 · Cited by 65
Metadata
- Authors
- Kaufman, D., Boyle, R., Hazen, K. C., Patrie, J. T., Robinson, M., & Donowitz, L. G.
- Affiliations
- University of Virginia (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2001-12-06
- Volume
- 345
- Issue
- 23
- Pages
- 1660-1666
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2016673581
- Cited by
- 523
- References
- 46
- Citations by year
- 2026: 3 · 2025: 10 · 2024: 13 · 2023: 9 · 2022: 10 · 2021: 8 · 2020: 8 · 2019: 21 · 2018: 17 · 2017: 18 · 2016: 19 · 2015: 18 · 2014: 24 · 2013: 26 · 2012: 42
- FWCI
- 12.45
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal and Maternal Infections
- Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
- Keywords
- fluconazole, antifungal prophylaxis, preterm infants, extremely low birth weight infants, invasive fungal infections, fungal colonization
- MeSH terms
- Antifungal Agents, Bacterial Infections, Candida, Candida albicans, Candidiasis, Double-Blind Method, Humans, Infant, Newborn, Infant, Premature, Infant, Premature, Diseases, Infusions, Intravenous, Microbial Sensitivity Tests, Mycoses, Prospective Studies, Trichosporon, Colony Count, Microbial, Fluconazole, Infant, Very Low Birth Weight
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.